Reference
- Doeglas D, Suurmeijer Th, Krol B, Sanderman R, van Leuwen M. Work disability in early RA. Ann Rheum Dis 1995;54:455–60.
- Suarez-Almazor M, Soskoline C, Saunders D, Russel A. Outcome in rheumatoid arthritis: a 1985 inception cohort study. J Rheumatol 1994;21: 1438–45.
- Guillemin F, Briancon S, Pourel J. Functional disability in early rheumatoid arthritis: two different models in early and established disease. J Rheumatol 1992;19:326–9.
- Felson DT, Anderson JJ, Meenan R. The comparative efficacy and toxicity of second line drugs in rheumatoid arthritis: results of two metaanalyses. Arthritis Rheum 1990;33:1449–61.
- Wilske K, Healey L. Remodeling the pyramid - a concept whose time has come. J Rheumatol 1989;16:565–7.
- Fries JF. Advances in management of rheumatic disease. Arch Intern Med 1989;149:1002–9.
- Sokka T, Hannonen P. Utility of disease modifying antirheu-matic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 years. Ann Rheum Dis 1999;58:618–22.
- Blanchard F, Briancon S, Guillemin F, van den Heuvel W, Manciaux M, Sandermann R, et al. European Research on Incapacitating Diseases and Social Support. Int J Health Sci 1990;1:217–28.
- Smedstad LM, Moum T, Guillemin F, Kvien TK, Finch MB, Suurmeijer Th, et al. Correlates of functional disability in early rheumatoid arthritis a cross-sectional study of 706 patients in four european countries. Br J Rheumatol 1996;35:746–51.
- Arnett F, Edworthy S, Bloch D, Mc Shane D, Fries J, Cooper N, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31: 315–23.
- Kaarela K, Kauppi M, Lehtinen H. The value of the ACR 1987 criteria in very early rheumatoid arthritis. Scand J Rheumatol 1995;24: 279–81.
- Guillemin F, Briancon S, Pourel J. Validity and discriminant ability of the HAQ functional index in early rheumatoid arthritis. Disabil Rehabil 1992;14:71–7.
- Reynolds JEF, Parfitt K, Swetman S, Parsons A. Council of the royal pharmaceutical society of Great Britain. Martindale: the extra pharmacopoeia. LONDON; Royal Pharmaceutical Society 1996.
- Nordiska Lakemedelsnamnanden, Nordic Council on Mede-cines. ATC and DDD. Reprint from NLN publication 1988;21:84–6.
- Constant F, Guillemin F, Herberth B, Collin J. Measurement methods of drug consumption as a secondary judgement criterion for clinical trials in chronic rheumatic diseases. Am J Epidemiol 1997;145:826–32.
- Pincus T. Rheumatoid arthritis: a medical emergency. Scand J Rheumatol 1994;23:21–30.
- Furst DE, Kremer J. Methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:305–11.
- Szanto E. Low dose methotrexate in rheumatoid arthritis: effect and tolerance. Scand J Rheumatol 1986;15:97–102.
- Guillemin F, Briancon S, Klein J-M, Sauleau E, Pourel J. Low incidence of rheumatoid arthritis in France. Scand J Rheumatol 1994;23:264–8.
- Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre 0. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998;25:1078–84.
- Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den Heuvel W. Compliance to drug treatment of RA patients: a three-year longitudinal study. J Rheumatol 1999;26:2114–22.
- Harris ED. The rationale for combination therapy of rheumatoid arthritis based on physiology. J Rheumatol 1996;23:2–4.
- Asit N, Le Loet X, Czemichow P, Bertho JM, Delcambre B, Tonnel F, et al. Comment le rhumatologue français traite-t-il, en pratique, la polyarthrite rhumatoide au debut? Rev Rhum 1996;63:199–207.
- Rodriguez G, Avina-Zubieta A, Fitzgerald A, Leclerq S, Suarez-Almazor M. Variations and trends in the prescription of initial second line therapy for patients with RA. J Rheumatol 1997;24:4–8.
- Wolfe F, Hawley D, Cathey M. Termination of slow acting antirheumatic therapy in RA: a 14-year prospecting evalua-tion of 1017 consecutive starts. J Rheumatol 1990;17: 994–1001.
- Ward F, Fries J. Trends in antirheumatic medication use among patients with RA 1981-96. J Rheumatol 1996; 25:408–16.
- Miedema H, van der Linden M, Rasker J, Valkenburg H. National database of patients visiting rheumatologists in the Netherlands. Br J Rheumatol 1998;37:555–61.
- Tosi F. Comparative analysis of health care systems in France, Netherlands, Norway and Sweden. Medecine Thesis. University of Nancy 1993:175p.